Overview
Brian Jensen is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Chapel Hill, North Carolina. Dr. Jensen is rated as an Experienced provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Cardiac Amyloidosis, Primary Localized Cutaneous Amyloidosis, Heart Failure, and Doxorubicin-Induced Cardiomyopathy.
His clinical research consists of co-authoring 78 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Cardiac Diagnostic Unit - Clinic 2K
Cardio-oncology is a relatively new field that’s at the intersection of cardiology and oncology. It’s been emerging with the increased awareness of cardiovascular disease in patients who have either been treated for cancer or who are being treated with cancer agents that may potentially cause heart complications. When patients come in, I evaluate if they are at higher risk for developing heart disease or complications and intervene to help prevent any issues. By protecting the heart, it allows us to treat our patients’ cancers as aggressively as possible. I also like to educate patients. This is based on my own experience with physicians. Instructions didn’t resonate with me without an explanation. Understanding gave me more buy-in. Now, when I see patients, I try to spend as much time as possible explaining the issues and find that at times even illustrating with pictures can help make things clearer. I think it helps patients to understand what is going on and feel more invested in their care. Dr. Khouri is rated as a Distinguished provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Cardiac Amyloidosis, Heart Failure, Primary Localized Cutaneous Amyloidosis, Cardiac Ablation, and Orchiectomy.
Duke Cardiology Clinic - Clinic 2F/2G
I am a cardiologist specializing in advanced heart failure and heart transplants. I see patients across the entire spectrum of heart failure, including early to late stages. In more advanced cases, I discuss the role of therapies, such as devices and heart transplants. My goal is to ensure that each patient receives optimal treatment for their condition. I provide a personalized approach to care and seek to understand the patient's unique story and journey. I enjoy answering questions about different treatment approaches and finding the right one for the patient. My passion for heart failure stems from excitement and appreciation for a growing number of effective treatment strategies in the field, and I look forward to discussing these with my patients. I am active in research, including clinical trials, and would be happy to discuss any opportunities to participate. In my free time, I enjoy getting to know the area, traveling, and spending time with my family. Dr. Selvaraj is rated as an Advanced provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Hypertension, and Cardiomyopathy.
0
I specialize in the care of patients with general and advanced heart failure. I look at each patient individually, yet apply the most advanced therapies for everyone. I have a particular interest in understanding the causes of heart failure, especially related to pregnancy and chemotherapy. I am also involved in a number of research projects evaluating new possible therapies for patients with heart failure. Outside of work, I enjoy cycling and spending time cycling with my wife and three boys. Dr. Russell is rated as a Distinguished provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Heart Failure, Cardiomyopathy, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Transplant, and Tissue Biopsy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cardiac AmyloidosisDr. Jensen isDistinguished. Learn about Cardiac Amyloidosis.
- Primary Localized Cutaneous AmyloidosisDr. Jensen isDistinguished. Learn about Primary Localized Cutaneous Amyloidosis.
- Advanced
- CardiomyopathyDr. Jensen isAdvanced. Learn about Cardiomyopathy.
- Cardiomyopathy Due to Anthracyclines
- Doxorubicin-Induced Cardiomyopathy
- Heart FailureDr. Jensen isAdvanced. Learn about Heart Failure.
- Pulmonary EdemaDr. Jensen isAdvanced. Learn about Pulmonary Edema.
- Experienced
- AnginaDr. Jensen isExperienced. Learn about Angina.
- ArrhythmiasDr. Jensen isExperienced. Learn about Arrhythmias.
- Arrhythmogenic Right Ventricular Cardiomyopathy
- AtherosclerosisDr. Jensen isExperienced. Learn about Atherosclerosis.
- Atrial FibrillationDr. Jensen isExperienced. Learn about Atrial Fibrillation.
- Atrial MyxomaDr. Jensen isExperienced. Learn about Atrial Myxoma.


